3 unchanged sentences
Based on the evaluation of our disclosure controls and procedures, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures as of December 31, 2020 were effective at the reasonable assurance level.
−Removed: Management’s annual report on internal control over financial reporting .
+Added: Management’s annual report on internal control over financial reporting .
Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act.
1 unchanged sentence
Based on its evaluation under the criteria set forth in Internal Control-Integrated Framework , our management concluded that our internal control over financial reporting was effective as of December 31, 2020.
−Removed: This annual report does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting.
−Removed: Management’s report was not subject to attestation by the Company’s registered public accounting firm pursuant to rules of the Securities and Exchange Commission that permit the Company to provide only management’s report in this Annual Report on Form 10-K.
+Added: This annual report does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting.
+Added: Management’s report was not subject to attestation by the Company’s registered public accounting firm pursuant to rules of the Securities and Exchange Commission that permit the Company to provide only management’s report in this Annual Report on Form 10-K.
Changes in internal control over financial reporting
33 unchanged sentences
Form of Warrant
−Removed: Description of Protagonist Therapeutics, Inc.’s Securities Registered Pursuant to Section 12 of the Exchange Act
−Removed: Protagonist Therapeutics, Inc.
−Removed: 2007 Stock Option and Incentive Plan, as amended and restated, and form of option agreement, exercise notice, joinder, and adoption agreement thereunder.
+Added: Description of Protagonist Therapeutics, Inc.’s Securities Registered Pursuant to Section 12 of the Exchange Act
Incorporation By Reference
1 unchanged sentence
Protagonist Therapeutics, Inc.
+Added: 2007 Stock Option and Incentive Plan, as amended and restated, and form of option agreement, exercise notice, joinder, and adoption agreement thereunder.
+Added: Protagonist Therapeutics, Inc.
2016 Equity Incentive Plan and forms of stock option grant notice, option agreement, notice of exercise, restricted stock unit grant notice and restricted stock unit agreement thereunder.
2 unchanged sentences
Form of Indemnity Agreement for Directors and Officers.
−Removed: Protagonist Therapeutics, Inc.
+Added: Amended and Restated Protagonist Therapeutics, Inc.
2018 Inducement Plan, form of stock option grant notice, form of option agreement, form of restricted stock unit grant notice and form of restricted stock unit agreement.
3 unchanged sentences
Employment Offer Letter, dated May 21, 2018, by and between the Registrant and Samuel Saks, M.D.
−Removed: 10.10†
Research and Collaboration Agreement, dated June 16, 2012, by and among the Registrant, Protagonist Pty.
and Zealand Pharma A/S.
−Removed: 10.11†
Contract Extension Letter of Agreement, dated June 1, 2013, by and among the Registrant, Protagonist Pty.
and Zealand Pharma A/S .
−Removed: 10.12†
Agreement on Addition of Additional Collaboration Program, dated September 16, 2013, by and among the Registrant, Protagonist Pty.
and Zealand Pharma A/S.
−Removed: 10.13†
+Added: Incorporation By Reference
+Added: Exhibit Description
Protagonist Assumption of Responsibility, dated January 28, 2014, by and between the Registrant and Zealand Pharma A/S.
−Removed: 10.14†
Agreement to Assign Patent Applications, dated February 7, 2014, by and between the Registrant, Protagonist Pty.
and Zealand Pharma A/S.
−Removed: Incorporation By Reference
−Removed: Exhibit Description
−Removed: 10.15†
Abandonment Agreement, dated February 28, 2014, by and among the Registrant, Protagonist Pty.
and Zealand Pharma A/S.
−Removed: 10.16†
Exclusive License and Collaboration Agreement, dated May 26, 2017, by and between the Registrant and Janssen Biotech, Inc.
10 unchanged sentences
and Donald Kalkofen, dated May 20, 2019.
+Added: Incorporation By Reference
+Added: Exhibit Description
Severance Agreement, dated July 19, 2019, by and between Protagonist Therapeutics, Inc.
3 unchanged sentences
and Jefferies LLC.
+Added: Severance Agreement, dated August 4, 2020, by and between Protagonist Therapeutics, Inc.
+Added: and Donald Kalkofen.
List of Subsidiaries
−Removed: Incorporation By Reference
−Removed: Exhibit Description
−Removed: Consent of Independent Registered Public Accounting Firm
+Added: Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm
+Added: Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm
Power of Attorney (included in signature page of this Form 10-K)
2 unchanged sentences
Certification of Chief Executive Officer and Chief Financial Officer, as required by Rule 13a-14(b) or Rule 15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C.
−Removed: §1350), as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
−Removed: XBRL Instance Document
−Removed: XBRL Taxonomy Extension Schema Document
−Removed: XBRL Taxonomy Extension Calculation Linkbase Document
−Removed: XBRL Taxonomy Extension Definition Linkbase Document
−Removed: XBRL Taxonomy Extension Labels Linkbase Document
−Removed: XBRL Taxonomy Extension Presentation Linkbase Document
+Added: §1350), as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
+Added: Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL Document
+Added: Inline XBRL Taxonomy Extension Schema Document
+Added: Incorporation By Reference
+Added: Exhibit Description
+Added: Inline XBRL Taxonomy Extension Calculation Linkbase Document
+Added: Inline XBRL Taxonomy Extension Definition Linkbase Document
+Added: Inline XBRL Taxonomy Extension Labels Linkbase Document
+Added: Inline XBRL Taxonomy Extension Presentation Linkbase Document
+Added: Cover Page Interactive Data File – the cover page interactive data file does into appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
+ Indicates management contract or compensatory plan, contract or agreement.
30 unchanged sentences
Bryan Giraudo
−Removed: /s/ Chaitan Khosla, Ph.D.
−Removed: March 10, 2020
−Removed: Chaitan Khosla, Ph.D.
/s/ Sarah Noonberg, M.D., Ph.D.
1 unchanged sentence
Sarah Noonberg, M.D., Ph.D.
+Added: /s/ Sarah O’Dowd
+Added: March 10, 2021
/s/ William D.
4 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.